Erdafitinib
Category: CancerErdafitinib Overview
Erdafitinib is a small molecule inhibitor of fibroblast growth factor receptor (FGFR) approved for treatment of cancer and marketed under the name Balversa. FGFRs are a subset of tyrosine kinases which are unregulated in some tumors and influence tumor cell differentiation, proliferation, angiogenesis, and cell survival.[1][2] Astex Pharmaceuticals discovered the drug and licensed it to Janssen Pharmaceuticals for further development.[1] Researc...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Erdafitinib
Recent Erdafitinib Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Erdafitinib
- Tablet: 3mg, 4mg, 5mg
Other drugs which contain Erdafitinib or a similar ingredient: (1 result)
- BALVERSA Erdafitinib